The Society of Physicians of Hong Kong

Infectious Disease

Topic	Issue
COVID-19 & Obesity - At the Intersection of a Pandemic and an Epidemic	AUGUST 2020 ‧ VOL. 12 ‧ NO. 7
Baloxavir, a New Weapon for an Old Enemy	MAY 2020 ‧ VOL. 12 ‧ NO. 5
Vaccinations in Rheumatic Disease Patients	MARCH 2020 ‧ VOL. 12 ‧ NO. 3
Cardiology, COVID-19 and Beyond	FEBRUARY 2020 ‧ VOL. 12 ‧ NO. 2
Updates on the Treatment of H. pylori Infections	JANUARY 2020 ‧ VOL. 12 ‧ NO. 1
Today's Science in Managing H. pylori Infection	SEPTEMBER 2018 ‧ VOL. 10 ‧ NO. 6
Intravenous Immunoglobulins (IVIg) in Sepsis	NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7
Novel Strategies for Influenza Vaccination	NOVEMBER 2017 ‧ VOL. 9 ‧ NO. 7
Elimination of Viral Hepatitis B and C	JULY 2017 ‧ VOL. 9 ‧ NO. 5
Sofosbuvir and Velpatasvir for All Genotypes of Chronic Hepatitis C Infection	JULY 2017 ‧ VOL. 9 ‧ NO. 5
Update on the Management of Chronic Hepatitis B Virus with Tenofovir - 2017	MAY 2017 ‧ VOL. 9 ‧ NO. 4
Treatment of Bacterial Pneumonia with Ceftaroline Fosamil in the Intensive Care Unit: A Retrospective Case Series of 10 Patients	MARCH 2017 ‧ VOL. 9 ‧ NO. 2
Current Management of Fungal Nail Infection (Onychomycosis)	SEPTEMBER 2016 ‧ VOL. 8 ‧ NO. 6
Updates in the Management of Chronic Hepatitis B and Hepatitis C	SEPTEMBER 2016 ‧ VOL. 8 ‧ NO. 6
Neurological and Psychiatric Syndromes of HIV	MAY 2016 ‧ VOL. 8 ‧ NO. 4
Oral Antiretroviral Therapy to Prevent Sexual Transmission of HIV	MAY 2016 ‧ VOL. 8 ‧ NO. 4
Streptococcus pneumoniae Infection: Prevention is Better than Cure	MARCH 2016 ‧ VOL. 8 ‧ NO. 3
What are Difficult Pneumonias? How do you Diagnose and Treat Them?	NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6
Antibiotic Prophylaxis to Prevent Infective Endocarditis	NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6
The Era of the Single Tablet Regimen (STR) for HIV Disease	NOVEMBER 2015 ‧ VOL. 7 ‧ NO. 6
Effective Management of Post-Influenza Pneumonia with a Novel Broad-Spectrum Cephalosporin	SEPTEMBER 2015 ‧ VOL. 7 ‧ NO. 5
Update on Pneumococcal Infection and Prevention	JANUARY 2015 ‧ VOL. 7 ‧ NO. 1
Advancements in the Treatment and Prevention of HIV Infection	DECEMBER 2014 ‧ VOL. 6 ‧ NO. 8
Management of Chronic Hepatitis B with Entecavir - Update in 2014	NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 7
Facts on the MRSA Superbug	NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 6
Current Management of HBV and HCC	NOVEMBER 2014 ‧ VOL. 6 ‧ NO. 6
Micafungin: Pros and Cons	JANUARY 2014 ‧ VOL. 6 ‧ NO. 1
Staphylococcus aureus and Atopic Dermatitis	NOVEMBER 2013 ‧ VOL. 5 ‧ NO. 6
Tenofovir for long-term HBV treatment: A 2013 update	SEPTEMBER 2013 ‧ VOL. 5 ‧ NO. 5
Management of Hepatitis C Infection: A 2013 Update	SEPTEMBER 2013 ‧ VOL. 5 ‧ NO. 5
Update on Chronic Hepatitis B: HBsAg Quantification and Tenofovir	SEPTEMBER 2012 ‧ VOL. 4 ‧ NO. 5
Management of Chronic Hepatitis B with Entecavir	JULY 2012 ‧ VOL. 4 ‧ NO. 4
Giving Chemotherapy or Intensive Immunosuppression to Patients Who Are Also Chronic Hepatitis B Carriers	MARCH 2011 ‧ VOL. 3 ‧ NO. 2
Practical Management of Community-acquired Pneumonia	DECEMBER 2010 ‧ VOL. 2 ‧ NO. 8
Clinical Evidence of the Quadrivalent HPV Vaccine in Adult Women over 26	MAY 2010 ‧ VOL. 2 ‧ NO. 3